Phase Genomics, Inc.
Biotechnology company · Seattle, Washington, United States
Phase Genomics, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2015. It has received 12 US government small-business research awards (SBIR/STTR) from health agencies, $14 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $4.8 million sold in a notice filed in 2023.
Phase Genomics at a glance
What does Phase Genomics do?
US government research funding
12 SBIR/STTR small-business research awards from US health agencies, $13.6 million in total (2016 to 2025). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institute of Child Health and Human Development.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $4.8 million sold (2023).
Frequently asked questions about Phase Genomics
Where is Phase Genomics headquartered?
Phase Genomics, Inc. is headquartered in Seattle, Washington, United States.
What does Phase Genomics do?
Phase Genomics, Inc. is a biotechnology company.
When was Phase Genomics founded?
The earliest incorporation on record for Phase Genomics, Inc. is in 2015, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
- Aurion Biotech, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences